__timestamp | Evotec SE | Perrigo Company plc |
---|---|---|
Wednesday, January 1, 2014 | 12404000 | 152500000 |
Thursday, January 1, 2015 | 18343000 | 187800000 |
Friday, January 1, 2016 | 18108000 | 184000000 |
Sunday, January 1, 2017 | 17614000 | 167700000 |
Monday, January 1, 2018 | 35619000 | 218600000 |
Tuesday, January 1, 2019 | 58432000 | 187400000 |
Wednesday, January 1, 2020 | 63945000 | 177700000 |
Friday, January 1, 2021 | 72200000 | 122000000 |
Saturday, January 1, 2022 | 76642000 | 123100000 |
Sunday, January 1, 2023 | 57519000 | 122500000 |
Unveiling the hidden dimensions of data
In the ever-evolving landscape of pharmaceuticals, research and development (R&D) investment is a critical driver of innovation and growth. Over the past decade, from 2014 to 2023, Perrigo Company plc and Evotec SE have demonstrated contrasting strategies in their R&D expenditures. Perrigo, a global leader in over-the-counter health and wellness solutions, consistently invested significantly more in R&D, with an average annual expenditure of approximately $164 million. In contrast, Evotec SE, a prominent player in drug discovery and development, averaged around $43 million annually.
Interestingly, while Perrigo's R&D spending peaked in 2018, Evotec's investment showed a steady upward trend, reaching its highest in 2022. This divergence highlights Perrigo's focus on maintaining a robust product pipeline, while Evotec's strategy emphasizes gradual, sustainable growth. As the pharmaceutical industry continues to innovate, these investment patterns offer valuable insights into the strategic priorities of these two companies.
Research and Development Investment: Eli Lilly and Company vs Perrigo Company plc
Research and Development Investment: Merck & Co., Inc. vs Evotec SE
Research and Development Expenses Breakdown: Gilead Sciences, Inc. vs Perrigo Company plc
Analyzing R&D Budgets: Dr. Reddy's Laboratories Limited vs Evotec SE
Research and Development: Comparing Key Metrics for PTC Therapeutics, Inc. and Perrigo Company plc
R&D Spending Showdown: Perrigo Company plc vs MannKind Corporation
Perrigo Company plc vs Wave Life Sciences Ltd.: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for Catalyst Pharmaceuticals, Inc. and Evotec SE
R&D Spending Showdown: HUTCHMED (China) Limited vs Evotec SE
Research and Development Investment: Protagonist Therapeutics, Inc. vs Evotec SE
Comparing Innovation Spending: Ligand Pharmaceuticals Incorporated and Evotec SE
R&D Spending Showdown: Evotec SE vs Xencor, Inc.